company

Great India Overseas Pvt. Ltd. dba Silkrute

Industry: pharmaceutical

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

Frequently asked questions

How many FDA warning letters has Great India Overseas Pvt. Ltd. dba Silkrute received?
Argus HQ has recorded 1 FDA warning letter for Great India Overseas Pvt. Ltd. dba Silkrute.
What FDA recalls has Great India Overseas Pvt. Ltd. dba Silkrute issued?
Argus HQ has not recorded an FDA recall tied to Great India Overseas Pvt. Ltd. dba Silkrute in our current dataset.
Is Great India Overseas Pvt. Ltd. dba Silkrute FDA compliant?
Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Great India Overseas Pvt. Ltd. dba Silkrute. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.